Impact of Bright Light Therapy on Prader-Willi Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-88
SponsorMaimonides Medical Center
About this trial
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Eligibility criteria
Qualifiers
Diagnosis of PWS confirmed by genetic testing
Score of 12 or above on the Epworth Sleepiness Scale (ESS).
Disqualifiers
Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
A history of previous treatment with LT
Patients presenting with active psychosis or mania
Trial design
Treatments tested in this trial
- Sham Light
- Bright Light Therapy
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Maimonides Medical Center
Lead sponsor
Foundation for Prader-Willi Research
Collaborator
Source ClinicalTrials.gov